ABBV Oct 2024 175.000 call
| Previous Close | 19.78 |
| Open | 21.75 |
| Bid | 19.10 |
| Ask | 21.65 |
| Strike | 175.00 |
| Expire Date | 2024-10-18 |
| Day's Range | 20.45 - 21.75 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 287 |
Insider MonkeyWhy Analysts Are Bullish on AbbVie Inc. (ABBV)
We recently published a list of 10 Best Big-Name Stocks to Buy Right Now According to Short Sellers. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other Best Big-Name Stocks to Buy Right Now According to Short Sellers. In early April 2024, Goldman Sachs Inc.’s data revealed […]
PR NewswireAllergan Aesthetics Launches BOTOX® Cosmetic (onabotulinumtoxinA) for Masseter Muscle Prominence (MMP) in Adults in China
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced that BOTOX® Cosmetic (onabotulinumtoxinA) is now available for the treatment of masseter muscle prominence (MMP) in China. The masseter is one of the muscles in the lower face involved in chewing, and prominence of the masseter muscle can result in a wide and square lower face shape1. BOTOX® Cosmetic was recently approved for the temporary improvement in the appearance of marked to very marked MMP in adults by the China Nationa
ZacksThe Zacks Analyst Blog Highlights Visa, AbbVie, Anheuser-Busch, Servotronics and United-Guardian
Visa, AbbVie, Anheuser-Busch, Servotronics and United-Guardian are included in this Analyst Blog.
